Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Year-over-year earnings per share growth rate
5Y CAGR
+10.8%/yr
Long-term compound
Percentile
P74
Within normal range
vs 5Y Ago
1.7x
Solid growth
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 26.32% |
| Q3 2025 | -42.42% |
| Q2 2025 | 73.68% |
| Q1 2025 | -34.48% |
| Q4 2024 | -35.56% |
| Q3 2024 | 32.35% |
| Q2 2024 | 25.93% |
| Q1 2024 | -10.00% |
| Q4 2023 | -3.23% |
| Q3 2023 | 14.81% |
| Q2 2023 | 80.00% |
| Q1 2023 | 0.00% |
| Q4 2022 | -50.00% |
| Q3 2022 | 25.00% |
| Q2 2022 | 20.00% |
| Q1 2022 | -28.57% |
| Q4 2021 | 7.69% |
| Q3 2021 | 13.04% |
| Q2 2021 | 15.00% |
| Q1 2021 | -9.09% |
| Q4 2020 | 15.79% |
| Q3 2020 | -24.00% |
| Q2 2020 | -3.85% |
| Q1 2020 | 0.00% |
| Q4 2019 | 13.04% |
| Q3 2019 | 27.78% |
| Q2 2019 | 12.50% |
| Q1 2019 | -15.79% |
| Q4 2018 | 26.67% |
| Q3 2018 | -6.25% |
| Q2 2018 | 6.67% |
| Q1 2018 | -82.56% |
| Q4 2017 | 616.67% |
| Q3 2017 | 9.09% |
| Q2 2017 | 175.00% |
| Q1 2017 | -1.72% |
| Q4 2016 | 103.50% |
| Q3 2016 | 100.00% |
| Q2 2016 | 5100.00% |
| Q1 2016 | -102.30% |